Collaboration aims to create the first-ever sublingual alprazolam powder, addressing the need for faster-acting anxiety ...
BUZZ BOMB™ captures over 400,000 views and a spike in online revenue driven by strategic brand expansion and Ashley ...
Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company") today announced that its wholly owned subsidiary ...
What’s Acer got going on over at its US warehouses, I wonder? While other manufacturers are struggling to get laptops under the $800 mark, Acer seems to be sitting on a never-ending supply of refurbs ...
Pharmaceutical Technology on MSN
Aspire Biopharma and Microsize collaborate for alprazolam powder formulation
Aspire Biopharma’s new sublingual powder bypasses digestion, delivering alprazolam directly for faster anxiety and panic relief.
ESTERO, FL / ACCESS Newswire / August 18, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), developer of a multi-faceted patent-pending drug delivery technology, today ...
H1 2026: Finalize formulation and manufacture test product. H1 2026 Initial Phase 1 pharmacokinetic clinical cross-over study. "Our pipeline is focused on research in therapeutic areas where we can ...
We looked globally for a partner that understood 'Quality' not just as testing, but as a culture.”— Gowri Shankar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results